Please ensure Javascript is enabled for purposes of website accessibility

Incyte(INCY)

Nasdaq Global Select

INCY
Incyte Stock Quote
$65.79 -$0.08 -0.1%
Price as of October 22, 2021, 4:00 p.m. ET View Interactive INCY Charts

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

Interactive Chart


Compare INCY Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
INCY
Incyte
$65.79 $15B -27.3% -25.4%
ILMN
$409.15 $64B 25.5% 187.6%
EXEL
$21.40 $7B -2.0% 89.5%
GILD
$67.24 $84B 15.7% 8.1%
BMY
$57.60 $128B -2.2% 35.8%

News & Analysis: Incyte

The Fool has written over 100 articles on Incyte.

All

Market Moves

Podcasts









Is Incyte Stock a Buy?

Is the biotech company worth its rich valuation metrics?